|Meridian makes SmallCap 600|
Thursday September 14, 10:39 am ET
Meridian Bioscience Inc. will be listed on the SmallCap 600, Standard & Poor's said Wednesday.
The Cincinnati-based biomedical company will replace MRO Software Inc. (NYSE: MRO - News), which is being acquired by IBM Corp. (NYSE: IBM - News), according to a MarketWatch report.
Meridian (NASDAQ: VIVO - News) will be listed on the SmallCap 600 after the close of trading Sept. 18. Shares of Meridian were trading at $23.94, up $1.52, Thursday morning.
The SmallCap 600 invests in 600 companies with a market capitalization of between $300 million and $2 billion. To be included, a company must also meet financial viability, liquidity and other trading requirements.